Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD)
Clinical trial NCT06897839 · RECRUITING
Trial details
- NCT number
- NCT06897839
- Sponsor
- Airway Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-03
- Primary completion
- 2028-03-31
- Enrollment
- 366
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.